Latest News

Check out the new PROPHET Publication “Concept paper on Strategic Research and Innovation Agenda (SRIA)”

Noncommunicable diseases (NCDs), also known as chronic diseases, are responsible for 80% of the disease burden which will continue to grow given the aging population and are the main cause of death. The majority of NCDs are preventable or can be delayed through interventions across the lifespan on the modifiable risk factors. By taking advantage […]

Check out the new PROPHET Publication “Concept paper on Strategic Research and Innovation Agenda (SRIA)” Read More »

PROPHET attended the “Medecine: Innovations and Challenges 2023” conference

PROPHET was present online at the “Medecine: Innovations and Challenges 2023” (MEDIC 2023) Conference last 29 November 2023. It was the occasion to introduce the project and to showcase two PROPHET results, the biomarkers mapping and the concept paper, presented respectively by Instituto de Salud Carlos III (ISCIII) and Karolinska Institutet (KI). Register here to stay

PROPHET attended the “Medecine: Innovations and Challenges 2023” conference Read More »

Joint webinar : Second International Experts Forum and Policy Dialogue

PROPHET, together with ENRICH GLOBAL Health Innovation Thematic Group and the IC2PerMed project, is organising a webinar : the Second International Experts Forum and Policy Dialogue taking place on 12 December 2023 from 11 am to 2 pm. This online workshop focuses on personalised medicine (PM), personalised prevention, biobanking, international collaboration on 12 December 2023 from 11

Joint webinar : Second International Experts Forum and Policy Dialogue Read More »

Evaluation of the clinical utility of personalized preventive approaches : first glance of the scoping review

PROPHET partners, including UTARTU (Tartu Ulikool) – UCSC (Universita Cattolica di Sacro Cuore) – INSA (Instituto Nacional de Saude Dr. Ricardo Jorge) – THL (Terveyden Ja Hvinvoinnin Laitos) and DEB (Debreceni Egyetem), participated to the scoping review that has been designed in order to identify general dimensions and specific process and outcomes indicators for the

Evaluation of the clinical utility of personalized preventive approaches : first glance of the scoping review Read More »

Workshop on returning genetic test results with familial consequences in the context of personalised prevention

On Monday 19th of June 2023 and Tuesday 20th of June 2023, a 2-day workshop was held in the historical city of Leuven (Belgium) with an expert panel consisting of several inter-disciplinary stakeholders who are leading work in the area of disclosure of genetic information to family members through research, clinical practice or policy. The

Workshop on returning genetic test results with familial consequences in the context of personalised prevention Read More »

Survey on barriers, challenges, and enablers for the adoption of personalised prevention strategies

We are happy to inform you that the survey that aims to map the barriers, challenges, and enablers for the adoption of personalised prevention strategies in Europe and beyond has been launched few weeks ago. Personalised prevention strategies are only possible if citizens, health professionals, researchers and policy makers are all aware of their potential

Survey on barriers, challenges, and enablers for the adoption of personalised prevention strategies Read More »

Defining personalised prevention

During the PROPHET kick-off meeting in Rome, September 2022, PROPHET partners worked on the definition of “personalised prevention” as follows: “Personalised prevention aims to prevent onset, progression and recurrence of diseases through the adoption of targeted interventions that consider the biological information*, environmental and behavioural characteristics, socio-economic and cultural context of individuals. This should be

Defining personalised prevention Read More »

Scroll to Top